LYVE1 and neoplasm: mECK36 tumor formation show consistent expression of the KS markers Podoplanin and LYVE-1, occurring with concomitant up-regulation of KSHV lytic oncogenes and angiogenesis ligands/ receptors, pointing to the upregulation of various receptor tyrosine kinase signaling axes[21].